Sleep Intervention for Suicidal Behavior
(TAILOR Trial)
Trial Summary
What is the purpose of this trial?
This study will test the effectiveness of a sleep-related primary suicide prevention program entitled TAILOR (Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior), which includes specific behavior-change strategies for adolescents at risk of suicidal behavior who suffer from difficulties falling asleep, staying asleep, and/or insufficient sleep.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have had a change in antipsychotic or mood stabilizer medications in the last 2 months, you may not be eligible to participate.
What data supports the effectiveness of the treatment Enhanced Usual Care, Duphalac, Kristalose, TAILOR, Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior?
Is the sleep intervention for suicidal behavior safe for humans?
The research suggests that managing sleep disturbances, such as insomnia and nightmares, is important for reducing suicide risk, but it does not provide specific safety data for the sleep intervention itself. However, therapeutic approaches like cognitive behavior therapy for insomnia and imagery rehearsal treatment are generally considered safe and show promise in treating sleep disorders and suicidal behavior.15678
What makes the TAILOR treatment unique for addressing suicidal behavior in adolescents?
The TAILOR treatment is unique because it specifically targets sleep disturbances, such as insomnia, which are linked to suicidal thoughts and behaviors in adolescents. By focusing on improving sleep, this treatment aims to reduce the risk of suicide, which is a novel approach compared to traditional methods that may not address sleep issues directly.12457
Research Team
Jeff Bridge
Principal Investigator
Nationwide Children's Hospital
Eligibility Criteria
This trial is for adolescents aged 11-18 who are patients at Nationwide Children's Hospital, have had suicidal thoughts and sleep problems recently, and live with a caregiver who can consent to research. It excludes those with certain sleep disorders, recent substance use, inadequate English skills, no phone or internet access, recent suicide attempt or medication changes.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the TAILOR intervention, which includes Cognitive Behavioral Therapy, Motivational Interviewing, and voice- or video call-based assistance over 2 months
Follow-up
Participants are monitored for changes in sleep problems and suicidal ideation at 2 and 4 months post-randomization
Treatment Details
Interventions
- Enhanced Usual Care
- TAILOR
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jeff Bridge
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator